(19)
(11) EP 0 594 842 B1

(12) EUROPEAN PATENT SPECIFICATION

(45) Mention of the grant of the patent:
16.07.1997 Bulletin 1997/29

(21) Application number: 93913874.9

(22) Date of filing: 12.05.1993
(51) International Patent Classification (IPC)6A61M 25/00
(86) International application number:
PCT/US9304/566
(87) International publication number:
WO 9323/108 (25.11.1993 Gazette 1993/28)

(54)

COEXTRUDED MEDICAL GRADE PORT TUBING

KOEXTRUDIERTES ROHR MEDIZINISCHER QUALITÄTSSTUFE

TUBULURE A ORIFICES COEXTRUDEE A USAGE MEDICAL


(84) Designated Contracting States:
AT BE CH DE DK ES FR GB IE IT LI NL SE

(30) Priority: 14.05.1992 US 883001

(43) Date of publication of application:
04.05.1994 Bulletin 1994/18

(73) Proprietor: BAXTER INTERNATIONAL INC.
Deerfield, IL 60015 (US)

(72) Inventors:
  • LO, Ying-Cheng
    Green Oaks, IL 60048 (US)
  • PATEL, Indrajit, T.
    Algonquin, IL 60102 (US)
  • WOO, Lecon
    Libertyville, IL 60048 (US)
  • CHEUNG, Y., Wilson
    Ahmerst, MA 01003 (US)
  • LING, Michael, T., K.
    Vernon Hills, IL 60061 (US)

(74) Representative: MacGregor, Gordon et al
ERIC POTTER CLARKSON St. Mary's Court St. Mary's Gate
Nottingham, NG1 1LE
Nottingham, NG1 1LE (GB)


(56) References cited: : 
EP-A- 0 203 630
EP-A- 0 310 143
EP-A- 0 564 231
EP-A- 0 216 639
EP-A- 0 380 270
US-A- 4 627 844
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).


    Description

    BACKGROUND OF THE INVENTION



    [0001] The present invention relates generally to medical grade port tubing.

    [0002] It is known in the medical industry to house products such as fluids that are administered to a patient in plastic containers.

    [0003] It is also known to use medical tubing, ports, to provide access either to a container or from a container. Such port tubing serves other purposes besides accessing the container, for example, as a conduit to a patient from a fluid source. Such medical port tubing has uses in such therapies as renal and blood.

    [0004] Examples of therapies wherein flexible containers including port tubing are used include intravenous therapy, continuous ambulatory dialysis (CAPD), and blood therapy. In CAPD, the container includes a dialysis fluid that can be infused into the peritoneal of the patient through a tube, port, fused to the container.

    [0005] Typically, for medical uses, there are a variety of characteristics that a medical port tube should have. Among the characteristics the port tube should exhibit is the ability to be RF (radio frequency) sealed to a material from which the container may be constructed. This allows the port tubing to be compatible with equipment used in certain of the medical industries. It is also desirable that the port tubing can be solvent bondable. For example, it is known in manufacturing containers with a port tubing to bond such tubings to a port closure (for example, PVC) using cyclohexanone to protect the sterility of the port tubing.

    [0006] Furthermore, such port tubing should be sufficiently flexible as well as translucent. Additionally, the port tubing, if it is coextruded, must not easily delaminate.

    [0007] Although most medical containers have been constructed from PVC, recently, much attention has been focused on constructing non-PVC containers. Such port tubing, if it is to be used with a non-PVC container, must be compatible therewith.

    [0008] EP-A-0564231 forms part of the state of the art under Article 54(3) EPC.

    SUMMARY OF THE INVENTION



    [0009] The present invention provides an improved coextruded medical port tubing as set out in Claim 1. The precharacterising part of Claim 1 is based on EP-A-380270, which discloses a medical grade tubing having an outer layer of ethylene propylene copolymer and SEBS. PVC is mentioned as a possible material for an inner layer of the tubing. The medical port tubing of the present invention provides characteristics that are desirable in the medical industry and therefore can be used as a medical port tubing in, for example, renal therapy or blood donor tubes. Furthermore, the port tubing can be used with a non-PVC container.

    [0010] To this end, the present invention provides a coextruded medical grade port tubing comprising: an outer layer comprising a blend of polypropylene copolymer and styrene-ethylene-butylene-styrene copolymer; a tie layer, and a core layer comprising polyvinyl chloride.

    [0011] In an embodiment, the tie layer comprises a blend of polyester, polypropylene copolymer, styrene-ethylene-butylene-styrene copolymer, and ethylene vinyl acetate. Preferably, the tie layer is a blend comprising:
    30 to 60 % by weight copolyester; 0 to 20 % by weight polypropylene copolymer; 30 to 60 % by weight styrene-ethylene-butylene-styrene copolymer; and 0 to 30 % by weight ethylene vinyl acetate.

    [0012] In an embodiment, the outer layer of the port tube comprises 40 to 99% by weight polypropylene copolymer and 1 to 60% by weight styrene-ethylene-butylene-styrene copolymer.

    [0013] In an embodiment, the present invention provides a coextruded medical grade port tubing comprising: an outer layer comprising a blend of polypropylene copolymer and styrene-ethylene-butylene-styrene copolymer; a tie layer comprising a blend of polyester, polypropylene copolymer, styrene-ethylene-butylene-styrene copolymer, and ethylene vinyl acetate; and a core layer of polyvinyl chloride. This structure allows the outer layer to be bonded to polyolefin surface layer film and allows the inner layer to be solvent bonded to PVC material.

    [0014] The layers of the port tubing have the following thickness ratios: outer layer 2.5 to 30% of the total cross-sectional thickness of the port tubing; tie layer 2.5 to 20% of the total cross-sectional thickness of the port tubing; and core layer 50 to 95% of the total cross-sectional thickness of the port tubing. The outer and tie layer are thin enough to allow rapid and sufficient heat transfer from the PVC heat generation layer to the outer layer for welding.

    [0015] Additional features and advantages of the present invention are described in, and will be apparent from, the detailed description of the presently preferred embodiments and from the drawings.

    BRIEF DESCRIPTION OF THE DRAWINGS



    [0016] Figure 1 illustrates a cross-sectional view of a coextruded port tube constructed pursuant to an embodiment of the present invention.

    [0017] Figure 2 illustrates a perspective view of a container including the port tubing of the present invention.

    DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED EMBODIMENTS



    [0018] The present invention provides a coextruded medical grade port tubing that achieves many of the characteristics that are desirable, in the medical industry, for such port tubing. For example, the port tubing, in an embodiment, exhibits RF sealability, ability to solvent bond, flexibility, translucence, and ability to not delaminate after severe bending or autoclaving.

    [0019] Referring to Figure 1, the present invention provides a coextruded medical grade port tubing 10 comprising: an outer layer 12 comprising a blend of polypropylene copolymer and styrene-ethylene-butylene-styrene copolymer; a tie layer 14 comprising preferably a blend of polyester, polypropylene copolymer, styrene-ethylene-butylene-styrene copolymer, and ethylene vinyl acetate; and a core layer 16 of polyvinyl chloride.

    [0020] The medical grade port tubing 10 is autoclavable and can be RF sealable to a non-PVC container having a polyolefin blend or polyolefin surfaces. Additionally, the composition can be solvent bonded to a PVC closure using cyclohexanone, MEK (methyl ethyl ketone) or other solvent. In this regard, the outer layer 12 is able to bond to a polyolefin surface layer film while the core layer 16 can be bonded to a PVC material.

    [0021] Preferably, the tie layer 14 is a blend of material comprising: 30 to 60% copolyester by weight, for example, Hytrel™ available from DuPont; 0 to 20% by weight polypropylene copolymer (2-6% by weight polyethylene); 30 to 60% by weight styrene-ethylene-butylene-styrene copolymer, for example, Kraton™; and 0 to 30% by weight ethylene vinyl acetate.

    [0022] Preferably, the outer layer 12 comprises 40 to 99% by weight polypropylene copolymer that includes 2 to 6% by weight polyethylene, and 1 to 60% by weight styrene-ethylene-butylene-styrene-copolymer, for example, Kraton™.

    [0023] The core layer 16 can comprise PVC plasticized with DEHP, or other material. Likewise, the core layer 16 can comprise non-plasticized PVC.

    [0024] The medical grade port tubing 10 has a structure so that it has the following ratio of layer thicknesses: the outer layer 12 comprises 2.5% to 30% of the total cross-sectional thickness of the port tube; the tie layer 14 comprises 2.5% to 20% of the total cross-sectional thickness of the tube; and the core layer 16 of the structure comprises 50% to 95% of the total cross-sectional thickness of the structure. By providing thin outer and tie layers 12 and 14, the port tubing 10 can be R.F. sealed to a plastic film.

    [0025] The resultant medical grade port tubing 10 is flexible and translucent. Accordingly, when used as a medical tubing, one can see air bubbles or needles, for example, through the port tubing. Additionally, the port tubing 10 does not easily delaminate even after severe bending either before or after autoclaving.

    [0026] The port tubing 10 of Figure 1 can be used with a medical container 20 illustrated in Figure 2. In a preferred embodiment, the container 20 is constructed from a non-PVC material. In a preferred embodiment, the container is constructed from a four layer film comprising: polypropylene copolymer,Kraton®/ethylene vinyl acetate/acid modified ethylene vinyl acetate/PCCE. (PCCE = polycyclohexanedimethylcyclohexanedicarboxylate elastomer.)

    [0027] The port tubing 10 provides access to and away from an interior 22 of the container 20. The port tubing 10 of the present invention is believed to be particularly suitable for use in renal applications, especially CAPD. However, the port tubing 10 can be used to construct other medical products.

    [0028] By way of example, and not limitation, examples of the present invention will now be given.

    EXAMPLE NO. 1



    [0029] Coextruded port tubings were constructed and evaluated as follows.

    [0030] The following materials were used:
    Core layer:
    DEHP Plasticized PVC;
    Tie layer:
    50 weight % Kraton G-1660™ (Shell);
    38 weight % Hytrel 4056™ (DuPont);
    10 weight % UE 697000™ (Quantum); and
    2 weight % Polypropylene copolymer 23M2™ (El Paso);
    Outer layer:
    60 weight % Polypropylene copolymer-Fina 8473™ (Fina);
    and
    40 weight % Styrene-ethylene-butylene-styrene - Kraton G-1652™ (Shell).


    [0031] The following processing conditions were used:
    • Nominal Setting
    Core Layer 1½" Davis Standard Tie Layer 1: Davis Standard
    Barrel Zone # Set Barrel Zone # Set
    1) 325°F 1) 450°F
    2) 325°F 2) 450°F
    3) 325°F 3) 450°F
    4) 325°F    
    (325°F = 162.8°C ; 450°F = 232.2°C)
    Die Zone # Set Die Zone # Set
    1) 325°F 1) 450°F
    Adapter 325°F    
    Screw R.P.M.: 60 AMPS: 12 Screw R.P.M. : 21 AMPS: 4
    Screw Type: Pin Screw Type Maddox
    Screw Pack: 40-60-40 Screw Pack: 40-60-40
    Head Pressure: 40.0x106 Pa (5800 P.S.I.) Head Pressure 1.24x106 Pa (180 P.S.I.)
    Outer Layer 1" Davis-Standard    
    Barrel Zone # Set (Tri Die Set-Up)
    1) 400°F Die Pin O.D.: .300" O.D.
    2) 400°F Die Bushing: .375" I.D.
    3) 400°F    
    Die Zone # Set (Vacuum Tank Set-Up)
    1) 400°F Sizer I.D.: .390"
        Water Temp.: 53.8"
        Vacuum:Pot. 25.5
        Setting  
        Die to Tank: 1"
    Screw R.P.M. : 18 AMPS: 4 Pull or Setting: 33 f.P.M.
    Screw Type: Barrier    
    Screw Pack: 40-60-40    
    Head Pressure: N/A    
    (400°F = 204.4°C ; 1" = 25.4 mm)


    [0032] The resultant port tubing included a core layer having a thickness of .71 mm, a tie layer of .05 mm, and an outer layer of .05 mm.

    [0033] The port tubing was autoclaved. The port tubing characteristics were then evaluated, after autoclaving, and are set forth below in the table. The bonding force between the outer and tie layer was found to be strong. An initial separation between the outer and tie layer could not be initiated. The bonding force between the tie and core layer was 39.29 to 42.86 kg/m (1.1 to 1.2 lbs./0.5 inches).
    PORT TUBING MATERIAL EVALUATION
    Tubing Materials Tubing Characteristics Post Autoclaving COMMENTS
      Processing Bond* Texture Bond* Texture  
    Example #1 Good 9 Smooth 9 Smooth Very difficult to peel
    1. Assume bonding strength of PVC to PVC by cyclohexanone is 10. Data results are subjective due to manual testing. (*)


    [0034] Example No. 1 demonstrates that the port tubing of the present invention meets the necessary requirements of a port tubing. Indeed, the port tubing exhibits characteristics that are better than current PVC port tubing since a typical PVC port will not bond to a non-PVC container.


    Claims

    1. A coextruded medical grade port tubing (10) comprising an outer layer (12) comprising a blend of polypropylene copolymer and styrene-ethylene-butylene-styrene copolymer; a tie layer (14); and a core layer (16) comprising polyvinyl chloride,
       characterised in that the layers have the following thickness ratios:

    outer layer (12): 2.5 to 30% of the total cross-sectional thickness of the port tubing;

    tie layer (14): 2.5 to 20% of the total cross-sectional thickness of the port tubing; and

    core layer (16): 50 to 95% of the total cross-sectional thickness of the port tubing.


     
    2. The coextruded medical grade port tubing of Claim 1 wherein the tie layer (14) comprises a blend of polyester, polypropylene copolymer, styrene-ethylene-butylene-styrene copolymer, and ethylene vinyl acetate.
     
    3. The coextruded medical grade port tubing of Claim 1 wherein the tie layer (14) is a blend comprising:

    30 to 60% by weight copolyester;

    0 to 20% by weight polypropylene copolymer;

    30 to 60% by weight styrene-ethylene-butylene-styrene copolymer; and

    0 to 30% by weight ethylene vinyl acetate.


     
    4. The medical grade port tubing of Claim 3 wherein the polypropylene copolymer of the tie layer (14) includes 2 to 6% by weight polyethylene.
     
    5. The coextruded medical port tubing of any preceding claim wherein the outer layer (12) comprises:

    40 to 99% by weight polypropylene copolymer; and

    1 to 60% by weight styrene-ethylene-butylene-styrene copolymer.


     
    6. The coextruded medical port tubing of Claim 5 wherein the outer layer (12) comprises 60% by weight polypropylene copolymer and 40% by weight styrene-ethylene-butylene-styrene.
     
    7. The coextruded medical grade port tubing of any preceding claim wherein the polypropylene copolymer comprises 2 to 6% by weight polyethylene.
     
    8. The coextruded medical grade port tubing of any preceding claim wherein the polyvinyl chloride includes a plasticizer.
     
    9. The coextruded medical grade port tubing of any one of preceding Claims 1 to 7 wherein the polyvinyl chloride does not include a plasticiser.
     
    10. A non-PVC medical container for housing medical fluid including a coextruded medical grade port tubing (10) according to any preceding claim.
     


    Ansprüche

    1. Coextrudierte Anschlußrohrleitung (10) medizinischer Qualitätsstufe, die folgendes aufweist:

    - eine Außenschicht (12), die eine Mischung aus einem Polypropylen-Copolymer und einem Styrol-Ethylen-Butylen-Styrol-Copolymer aufweist;

    - eine Verbindungsschicht (14); und

    - eine Kernschicht (16), die Polyvinylchlorid aufweist,

    dadurch gekennzeichnet, daß die Schichten die folgenden Dickenverhältnisse aufweisen:

    - Außenschicht (12) : 2,5 bis 30 % der Gesamtquerschnittsdicke der Anschlußrohrleitung;

    - Verbindungsschicht (14) : 2,5 bis 20 % der Gesamtquerschnittsdicke der Anschlußrohrleitung; und

    - Kernschicht (14) : 50 bis 95 % der Gesamtquerschnittsdicke der Anschlußrohrleitung.


     
    2. Coextrudierte Anschlußrohrleitung medizinischer Qualitätsstufe nach Anspruch 1,
    wobei die Verbindungsschicht (14) eine Mischung aus Polyester, Polypropylen-Copolymer, Styrol-Ethylen-Butylen-Styrol-Copolymer und Ethylen-Vinylacetat enthält.
     
    3. Coextrudierte Anschlußrohrleitung medizinischer Qualitätsstufe nach Anspruch 1,
    wobei die Verbindungsschicht (14) eine Mischung ist, die folgendes enthält:

    - 30 bis 60 Gew.-% Copolyester;

    - 0 bis 20 Gew.-% Polypropylen-Copolymer;

    - 30 bis 60 Gew.-% Styrol-Ethylen-Butylen-Styrol-Copolymer; und

    - 0 bis 30 Gew.-% Ethylen-Vinylacetat.


     
    4. Coextrudierte Anschlußrohrleitung medizinischer Qualitätsstufe nach Anspruch 3,
    wobei das Polypropylen-Copolymer der Verbindungsschicht (14) 2 bis 6 Gew.-% Polyethylen enthält.
     
    5. Coextrudierte Anschlußrohrleitung medizinischer Qualitätsstufe nach einem der vorhergehenden Ansprüche,
    wobei die Außenschicht (12) folgendes enthält:

    - 40 bis 99 Gew.-% Polypropylen-Copolymer; und

    - 1 bis 60 Gew.-% Styrol-Ethylen-Butylen-Styrol-Copolymer.


     
    6. Coextrudierte Anschlußrohrleitung medizinischer Qualitätsstufe nach Anspruch 5,
    wobei die Außenschicht (12) 60 Gew.-% Polypropylen-Copolymer und 40 Gew.-% Styrol-Ethylen-Butylen-Styrol-Copolymer enthält.
     
    7. Coextrudierte Anschlußrohrleitung medizinischer Qualitätsstufe nach einem der vorhergehenden Ansprüche,
    wobei das Polypropylen-Copolymer 2 bis 6 Gew.-% Polyethylen enthält.
     
    8. Coextrudierte Anschlußrohrleitung medizinischer Qualitätsstufe nach einem der vorhergehenden Ansprüche,
    wobei das Polyvinylchlorid einen Weichmacher enthält.
     
    9. Coextrudierte Anschlußrohrleitung medizinischer Qualitätsstufe nach einem der vorhergehenden Ansprüche 1 bis 7,
    wobei das Polyvinylchlorid keinen Weichmacher enthält.
     
    10. Nicht aus PVC bestehender medizinischer Behälter zur Aufnahme medizinischer Fluide, der eine coextrudierte Anschlußrohrleitung (10) medizinischer Qualitätsstufe (10) gemäß einem der vorhergehenden Ansprüche aufweist.
     


    Revendications

    1. Tubulure à orifices coextrudée à usage médical (10) comprenant une couche extérieure (12) composée d'un mélange de copolymère de polypropylène et de copolymère styrène-éthylène-butylène-styrène ; une couche adhésive (14) ; et une couche centrale (16) composée de polychlorure de vinyle ;
       caractérisée en ce que les couches ont les rapports d'épaisseur suivants :

    couche extérieure (12) : 2,5 à 30 % de l'épaisseur totale en section transversale de la tubulure à orifices ;

    couche adhésive (14) : 2,5 à 20 % de l'épaisseur totale en section transversale de la tubulure à orifices ;

    couche centrale (16) : 50 à 95 % de l'épaisseur totale en section transversale de la tubulure à orifices.


     
    2. Tubulure à orifices coextrudée à usage médical selon la revendication 1, dans laquelle la couche adhésive (14) se compose d'un mélange de polyester, copolymère de polypropylène, copolymère styrène-éthylène-butylène-styrène et acétate de vinyle éthylénique.
     
    3. Tubulure à orifices coextrudée à usage médical selon la revendication 1, dans laquelle la couche adhésive (14) est un mélange comprenant :

    30 à 60 % en poids de copolyester ;

    0 à 20 % en poids de copolymère de polypropylène ;

    30 à 60 % en poids de copolymère styrène-éthylène-butylène-styrène ; et

    0 à 30 % en poids d'éthylènevinylacétate.


     
    4. Tubulure à orifices à usage médical selon la revendication 3, dans laquelle le copolymère de polypropylène de la couche adhésive (14) comprend 2 à 6 % en poids de polyéthylène.
     
    5. Tubulure à orifices coextrudée à usage médical selon l'une quelconque des revendications précédentes, dans laquelle la couche extérieure (12) comprend :

    40 à 99 % en poids de copolymère de polypropylène ; et

    1 à 60 % en poids de copolymère styrène-éthylène-butylène-styrène.


     
    6. Tubulure à orifices coextrudée à usage médical selon la revendication 5, dans laquelle la couche extérieure (12) comprend 60 % en poids de copolymère de polypropylène et 40 % en poids de styrène-éthylène-butylène-styrène.
     
    7. Tubulure à orifices coextrudée à usage médical selon l'une quelconque des revendications précédentes, dans laquelle le copolymère de polypropylène comprend 2 à 6 % en poids de polyéthylène.
     
    8. Tubulure à orifices coextrudée à usage médical selon l'une quelconque des revendications précédentes, dans laquelle le polychlorure de vinyle comprend un plastifiant.
     
    9. Tubulure à orifices coextrudée à usage médical selon l'une quelconque des revendications 1 à 7, dans laquelle le polychlorure de vinyle ne contient pas de plastifiant.
     
    10. Récipient à usage médical autre qu'en PVC destiné à contenir un fluide médical comprenant une tubulure à orifices coextrudée à usage médical (10) selon l'une quelconque des revendications précédentes.
     




    Drawing